Companies: 10,795·Total market cap: $144.5T

Amgen Inc.

Amgen Inc.

AMGNNASDAQHealthcare● Active

$349.58

+$3.98(+1.15%)

Market Cap$188.7B

P/E Ratio—

52W High$391.29

52W Low$267.83

Avg Volume2.6M

Open$348.68

Beta0.42

股票排行：Drug Manufacturers - General·Healthcare·查看全部市值排行 →

Amgen Inc.（AMGN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · AMGN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$14.48Earnings history

PE Ratio (TTM)24.1×PE Ratio deep dive

Revenue (TTM)$37.2BFull revenue history

Dividend Yield3.00%Dividend history

Shares Outstanding538.0MShares outstanding history

Next EarningsAug 4, 2026Est.Earnings history

探索 Amgen Inc. 数据

分析师预测$353 · Buy

营收$36.7B+9.92%

盈利EPS $14.33+88.06%

市盈率24.1×

财务快照

FY 2025Revenue$36.74B▲ +9.92% YoY

202320242025

FY 2025Net Income$7.71B▲ +88.53% YoY

202320242025

FY 2025EPS$14.33▲ +88.06% YoY

202320242025

TTM:Revenue: $37.24BNet Income: $7.80BEPS: $14.48View income statement →

分析师评级与目标价

Buy38 位分析师

Strong Buy

0

Buy

22

Hold

13

Sell

3

Strong Sell

0

12-Month Price Target

$185.00Low

$349.58Current

$353.06Avg Target上涨空间 1.00%

$427.00High

合计: 38 · 买入占比: 57.9%

根据过去 3 个月内 38 位华尔街分析师，AMGN 共识评级为 Buy，12 个月平均目标价 $353.06 （较现价 $349.58 上涨空间 1.00%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$349.58+1.15%$188.7B #2

Bristol-Myers Squibb Company

$57.27+1.18%$116.9B #3

Boston Scientific Corporation

$48.55-0.61%$72.2B #4

Danaher Corporation

$184.30-1.25%$130.4B #5

Gilead Sciences, Inc.

$129.16-0.02%$160.4B #6

$51.52+0.49%$103.6B

股票表现

1D+1.15%

1W+6.59%

1M+5.39%

3M-5.40%

YTD+6.80%

1Y+20.55%

5Y+47.61%

关于 Amgen Inc.

CEORobert A. Bradway

IPO DateJun 17, 1983

Employees28,000

CountryUS

Websiteamgen.com

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscie…

Drug Manufacturers - General HealthcareNASDAQUS

关于股票概览与关键数据

Amgen Inc.（AMGN）是 Drug Manufacturers - General 行业的 Healthcare 类公司，于 Jun 17, 1983 在 NASDAQ 上市。截至最近交易日，AMGN 股价为 $349.58，市值约为 $188.7B。过去12个月累计回报 +20.55%，年初至今回报 +6.80%。

根据 38 位华尔街分析师，Amgen Inc. 股票共识评级为Buy，12个月平均目标价为 $353.06。2025 财年 Amgen Inc. 营收 $36.7B，净利润 $7.7B。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Amgen Inc.（AMGN）股价为 $349.58，在 NASDAQ 上市，52周区间为 $267.83 – $391.29。

AMGN 最新股价AMGN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议